Details of the Drug Combinations

General Information of This Drug (ID: DM05WIU)

Drug Name
PBI-05204   DM05WIU
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 2 [1]
Solid tumour/cancer 2A00-2F9Z Phase 2 [2]
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
PBI-05204 + Docetaxel DCY8YDU Docetaxel Chemotherapeutic Agent Toxicity [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02329717) Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT01562301) Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)